Given the unique ability of cDC1 to cross-present tumor antigens to CD8 T cells as well as their ability to engage CD4 T cells, they are regarded as the primary DC subset that orchestrates antitumor T cell responses. This evidence concerns the gene CD4 and neoplasm.